Exam 2 lecture 9 Flashcards
polymorphic vs monomorphic VT
polymorphic- torsades de pointes
monomorphic vt- ventricular tachycardia
mechanism of VT
increased ventricular automaticity
re entry
most common risk factors for ventricular tachycardia
MI and HFrEF
drugs that can cause VT
flecanide
propafenone
digoxin
prognostic significance of VT
sustained VT may lead to VF which is life threatening
pts with sustained VT are at risk for syndrome of sudden cardiac death
Drugs for VT
procainamide
Amiodarone
Sotalol
Verapamil
BB
procainamide VT treatment loading and maintenance dose
loading- 10-17 mg/kg IV at 20-50 mg/min
maintenance- 1-4 mg/min continous IV
Amiodarone VT treatment loading and maintenance dose
Loading- 150 mg IV over 10 mins
maintenance- 1mg/min continous IV for 6 hrs, then 0.5 mg/min for 18 hrs
sotalol VT treatment loading and maintenance dose
Loading- 75 mg IV every 12 hrs
no maintenance dose
verapamil VT treatment loading and maintenance dosing
Loading- 2.5-5 mg IV every 15-30 min at 1-3 mg/min
BB VT treatment loading and maintenance dose
Esmolol, metoprolol and propanolol IV same dose as A fib
VT treatment with structural heart disease
elective DCC
IV procainamide
IV amiodarone
if VT not terminated do DCC
How to treat VT with no structural heart disease
verapamil sensitive VT- verapamil
outflow tract VT-BB
if not terminated use DCC
how to prevent recurrence of ventricular tachycardia
ICD withwither amiodarone or sotalol
dose of amiodarone to give with ICD for prevention of recurrence of VT
400 mg po QD